InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,308.13
(
0.09%
)
US TECH 100
18,175.60
(
-0.11%
)
Dow Jones
39,806.77
(
-0.49%
)
Brent Oil
82.53
(
-1.20%
)
Bitcoin
71,237.11
(
-0.30%
)
Post# of 48085
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

linkvest

Send PM Follow Ignore
Followers 1233
Posts 77427
Boards Moderated 0
Alias Born 10/13/2011

linkvest

Member Level

Re: None

Thursday, 03/09/2023 12:44:27 PM

Thursday, March 09, 2023 12:44:27 PM

Post# of 48085
PPCB... Waiting on news... What a company: Clinical stage biopharma company developing novel
cancer treatments for patients suffering from
pancreatic, ovarian and colorectal cancers.
• Publicly traded on OTC Pink: PPCB, Fully Reporting.
• Proenzyme therapy approach based on 100 yrs. of
enzyme use.
• US FDA Orphan drug designation status for
treatment of pancreatic cancer.
• Key figures:
• $22M raised since company inception.
• 40 years combined pharma/biotech experience.
• 80 years combined scientific research expertise.
• 65 patents either in force or pending.



I'm here for my money

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up